id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-E-3565-0006,FDA,FDA-2024-E-3565,Determination of Regulatory Review Period for Purposes of Patent Extension; LIMFLOW SYSTEM,Notice,Determinations,2026-02-26T05:00:00Z,2026,2,2026-02-26T05:00:00Z,2026-04-28T03:59:59Z,2026-02-26T20:38:14Z,2026-03855,1,0,09000064b91e03ee
FDA-2024-E-3565-0005,FDA,FDA-2024-E-3565,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2025-12-02T05:00:00Z,2025,12,2025-12-02T05:00:00Z,,2025-12-03T01:37:16Z,,0,0,09000064b90aaa43
FDA-2024-E-3565-0004,FDA,FDA-2024-E-3565,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2025-06-30T04:00:00Z,2025,6,2025-06-30T04:00:00Z,,2025-06-30T23:25:12Z,,0,0,09000064b8e457a4
FDA-2024-E-3565-0001,FDA,FDA-2024-E-3565,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:11:34Z,,0,0,090000648660d672
FDA-2024-E-3565-0002,FDA,FDA-2024-E-3565,"Patent Extension Application from Knobbe, Martens, Olson & Bear, LLP (on behalf of LimFlow GmbH (""LimFlow""))",Other,Application,2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:11:56Z,,0,0,090000648660d674
FDA-2024-E-3565-0003,FDA,FDA-2024-E-3565,Requirement for Information,Other,Letter(s),2024-08-09T04:00:00Z,2024,8,2024-08-09T04:00:00Z,,2024-08-09T18:12:25Z,,0,0,090000648660d675